GlassScriptPhysician profile
Anthony R Cucuzzella
NPI 1144283417
$3,725.62
in general payments reported to CMS, 2019-2025
16 companies · $482 in 2025
The $482 reported for 2025 was more than what 78% of Physical Medicine & Rehabilitation providers received nationally (typical 2025 total: $138).
See the full distribution for Physical Medicine & Rehabilitation
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $169 · 2020: $242 · 2021: $160 · 2022: $410 · 2023: $568 · 2024: $1,695 · 2025: $482.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,958 · Travel and Lodging: $786.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,958.16 |
| Travel and Lodging | $786.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $1,406.34 | 2022-2025 | Intracept, Wavewriter Alpha Prime 16 |
| Abbott Laboratories | $1,067.89 | 2021-2025 | Proclaim, Octrode, Ionicrf |
| Galderma Laboratories, L.P. | $378.92 | 2019-2025 | |
| Medtronic, INC. | $208.00 | 2021-2025 | Intellis Adaptivestim, Inceptiv |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $134.99 | 2024-2025 | Relistor |
| Nevro Corp. | $117.25 | 2021-2024 | Senza |
| Si-Bone, INC. | $94.56 | 2022-2023 | |
| Merz North America, INC. | $59.72 | 2023 | Xeomin |
| Appliedvr INC | $49.48 | 2025 | Relievrx |
| Ibsa Pharma INC. | $47.87 | 2024 | Tirosint, Licart |
| Abbvie INC. | $45.14 | 2022-2023 | Botox |
| Biotronik Nro, INC. | $38.68 | 2025 | Prospera |
| Medtronic USA, INC. | $27.77 | 2019-2020 | |
| Ipsen Biopharmaceuticals, INC | $20.66 | 2019 | |
| Allergan, INC. | $14.28 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Globus Medical, INC. | $14.07 | 2025 | Senza |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anthony Cucuzzella listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.